Hemas Holdings PLC Stock

Equities

HHL.N0000

LK0337N00002

Consumer Goods Conglomerates

End-of-day quote Colombo S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
85 LKR 0.00% Intraday chart for Hemas Holdings PLC -3.30% +27.44%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 120B 404M Sales 2025 * 132B 443M Capitalization 51.91B 174M
Net income 2024 * 6.14B 20.61M Net income 2025 * 6.55B 21.97M EV / Sales 2024 * 0.43 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.39 x
P/E ratio 2024 *
8.45 x
P/E ratio 2025 *
7.93 x
Employees 4,740
Yield 2024 *
3.83%
Yield 2025 *
4.79%
Free-Float 28.67%
More Fundamentals * Assessed data
Dynamic Chart
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO CI
Hemas Holdings PLC Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Hemas Holdings PLC (COSE:HHL.N0000) acquired remaining 24.9% stake in Atlas Axillia Co. Ltd from Nirmal Anrudha Madanayake for LKR 3.4 billion. CI
Hemas Holdings PLC Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023 CI
Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023 CI
Hemas Holdings PLC Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Hemas Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
1 week-3.30%
Current month-3.85%
1 month+2.41%
3 months+14.86%
6 months+18.06%
Current year+27.44%
More quotes
1 week
84.00
Extreme 84
87.10
1 month
79.00
Extreme 79
89.10
Current year
67.00
Extreme 67
89.10
1 year
61.00
Extreme 61
89.10
3 years
39.00
Extreme 39
89.10
5 years
39.00
Extreme 39
107.00
10 years
39.00
Extreme 39
149.42
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01-12-31
Director of Finance/CFO - 23-05-31
Chairman 62 97-09-30
Members of the board TitleAgeSince
Director/Board Member - 98-08-31
Director/Board Member 72 91-04-30
Director/Board Member 64 91-04-30
More insiders
Date Price Change Volume
24-05-10 87 +2.35% 225,595
24-05-09 85 0.00% 203,389
24-05-08 85 -0.23% 26,214
24-05-07 85.2 -1.50% 89,639
24-05-06 86.5 -0.69% 114,121

End-of-day quote Colombo S.E., May 08, 2024

More quotes
Hemas Holdings PLC is a Sri Lanka-based holding company, which is engaged in investment activities and provides advisory services to other companies in the Hemas Group. The Company’s segments include Consumer Brands, Healthcare, Mobility and Other. Consumer Brands segment offers a range of products for babies and adults in hair care, skin care, toiletries, fragrances, and oral care under the brands Kumarika, Clogard and Velvet, among others. Its brand Atlas Axillia provides school stationery and notebooks, pens, pencils, and color products. Healthcare segment is engaged in healthcare services which include pharmaceutical distribution and hospitals services under its business Hemas Hospitals, Hemas Pharmaceuticals and Morison. Mobility segment is engaged in haulage, container yard operations, warehousing, automotive logistics, transportation of project, and over-dimensional cargo services. The Company has its operations in Sri Lanka, Bangladesh, West Bengal, and Myanmar.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
87 LKR
Average target price
98.97 LKR
Spread / Average Target
+13.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HHL.N0000 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW